Zonisamide Versus Propranolol in Migraine
Conditions: Migraine Interventions: Drug: Zonisamide 50 MG; Drug: Propranolol Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Conditions: Cardiovascular Disease Interventions: Drug: Propranolol; Drug: Placebo Sponsors: University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); University of California, Los Angeles; Dartmouth College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Propranolol for the Treatment of Traumatic Brain Injury
Conditions: TBI (Traumatic Brain Injury) Interventions: Drug: Propranolol; Drug: Placebo Sponsors: London Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.
Conditions: Migraine Interventions: Drug: Pizotifen; Drug: Amitriptyline-propranolol Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.
Conditions: Pancreatic Cancer; Surgery Interventions: Drug: Propranolol; Drug: Placebo Sponsors: Zealand University Hospital; Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Propranolol in Primary Progressive Aphasia
Conditions: Aphasia, Primary Progressive Interventions: Drug: Propranolol; Device: Magnetic Resonance Imaging (MRI); Drug: Placebo Sponsors: University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Molecular Basis of Loss Aversion
Condition: Healthy Interventions: Drug: single-dose madopar, single-dose propranolol, and single-dose placebo by order; Drug: single-dose madopar, single-dose placebo, and single-dose propranolol by order; Drug: single-dose propranolol, single-dose madopar, and single-dose placebo by order; Drug: single-dose propranolol , single-dose placebo, and single-dose madopar by order; Drug: single-dose placebo, single-dose propranolol, and single-dose madopar by order; Drug: single-dose placebo, single-dose madopar, and single-dose propranolol by order Sponsor: Sir Run Run Shaw Hospital Not yet recruitin...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
